TECH News and Press, Bio-Techne Corp

2026-06-25 17:43:42 ET Bio-Techne (NASDAQ:TECH) , a life science reagents, instruments, and bioprocessing tools provider, closed at $70.67, up 20.02%. Merck KGaA’s $73-per-share cash offer drove the move, and investors are watching the deal timetable and any updates on cl...

2026-06-25 14:45:01 ET Merck KGaA (ETR:MRK,OTCPL:MKGAF) has agreed to acquire life sciences supplier Bio-Techne (NASDAQ:TECH) for US$11.3 billion in cash, marking the firm’s largest transaction in a decade . Under a definitive agreement announced on Thursday (June...

2026-06-25 13:59:34 ET More on Merck, Eli Lilly, etc. Is GSK Quietly Becoming An Oncology Powerhouse AbbVie Inc. (ABBV) Apogee Therapeutics, Inc. - M&A Call - Slideshow AbbVie Inc. (ABBV) M&A Call Transcript Eli Lilly's Foundayo, Zepbound available to...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. ...

2026-06-25 13:28:01 ET Healthcare ETFs: ( XLV ), ( VHT ), ( IYH ), ( XHE ), ( IHI ), ( XBI ), ( PBE ), ( IDNA ) ...

2026-06-25 13:15:03 ET Market Perform from Leerink Partners issued a price target of $73.00 for TECH on 2026-06-25 15:20:53. The adjusted price target was set to $73.00. At the time of the announcement, TECH was trading at $70.545. The overall price target consensus is a...

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options a...

2026-06-25 06:21:46 ET More on Bio-Techne, Merck KGaA Merck KGaA (MKKGY) Presents at DbAccess European Champions Conference 2026 - Slideshow Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript Merck KGaA 2026 Q1 - Results - Earnings Call Presentation Bio-Tech...

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets PR Newswire Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) ...

2026-06-21 09:05:47 ET More on State Street Health Care Select Sector SPDR ETF AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit These small-cap healthcare stocks pair revenue growth with at...